Qvar 100micrograms/dose Easi-Breathe inhaler

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

유효 성분:

Beclometasone dipropionate

제공처:

Teva UK Ltd

ATC 코드:

R03BA01

INN (국제 이름):

Beclometasone dipropionate

복용량:

100microgram/1dose

약제 형태:

Pressurised inhalation

관리 경로:

Inhalation

수업:

No Controlled Drug Status

처방전 유형:

Caution - AMP level prescribing advised

제품 요약:

BNF: 03020000; GTIN: 5023497166610

환자 정보 전단

PACKAGE LEAFLET: INFORMATION FOR THE USER
QVAR® EASI-BREATHE® 50 MICROGRAMS PER ACTUATION INHALER
QVAR® EASI-BREATHE® 100 MICROGRAMS PER ACTUATION INHALER
BECLOMETASONE DIPROPIONATE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not
listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Qvar Easi-Breathe Inhaler is and what it is used for
2.
What you need to know before you use Qvar Easi-Breathe Inhaler
3.
How to use Qvar Easi-Breathe Inhaler
4.
Possible side effects
5.
How to store Qvar Easi-Breathe Inhaler
6.
Contents of the pack and other information
1.
WHAT QVAR EASI-BREATHE INHALER IS AND WHAT IT IS USED FOR
Qvar Easi-Breathe Inhaler contains beclometasone dipropionate, which
belongs to a group of medicines
known as corticosteroids.
Qvar Easi-Breathe Inhaler is used to prevent the symptoms of mild,
moderate, or severe asthma in patients
who require regular treatment.
HOW YOUR MEDICINE WORKS

Qvar Easi-Breathe Inhaler works deep in your lungs to make breathing
easier by reducing the
inflammation, swelling, and irritation in the airways. This type of
medicine is known as a ‘preventer’. It
needs to be taken regularly every day, even if you have no symptoms.

This inhaler will not give immediate relief of wheezing or
breathlessness during a sudden asthma attack.
You will need to use a ‘reliever’ inhaler, which contains a
different medicine. You should still continue
to use this inhaler.

you are suffering from a sudden attack of breathlessness. It will not
help. Use a quick-acting ‘reliever’
inhaler for this purpose and

제품 특성 요약

OBJECT 1
QVAR 100 EASI-BREATHE
Summary of Product Characteristics Updated 19-Oct-2017 | Teva UK
Limited
1. Name of the medicinal product
Qvar Easi-Breathe 100 micrograms per actuation pressurised inhalation
solution
2. Qualitative and quantitative composition
Beclometasone Dipropionate 100 micrograms per metered (ex-valve) dose.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with
a metering valve and an actuator.
Qvar Easi-Breathe contains a propellant, which does not contain any
chlorofluorocarbons (CFCs).
4. Clinical particulars
4.1 Therapeutic indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology and method of administration
Posology
Qvar Easi-Breathe is for inhalation use only.
Patients should be instructed in the proper use of their inhaler,
including rinsing out their mouth with
water after use..
NOTE: THE RECOMMENDED TOTAL DAILY DOSE OF QVAR EASI-BREATHE IS LOWER
THAN THAT FOR CURRENT
BECLOMETASONE DIPROPIONATE CONTAINING PRODUCTS AND SHOULD BE ADJUSTED
TO THE NEEDS OF THE
INDIVIDUAL PATIENT.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise
pulmonary function as soon as possible.
When patients' symptoms remain under satisfactory control, the dose
should be titrated to the lowest dose
at which effective control of asthma is maintained.
To be effective inhaled Qvar Easi-Breathe must be used on a regular
basis even when patients are
asymptomatic.
THERAPY IN NEW PATIENTS SHOULD BE INITIATED AT THE FOLLOWING
Mild asthma:
100 to 200 micrograms per day in two divided doses.
Moderate asthma:
200 to 400 micrograms per day in two divided doses.
Severe asthma:
400 to 800 micrograms per day in two divided doses.
Patients on budesonide inhalers may be transferred to Qvar as
described below
The general approach to switching patients to Qvar involves two steps
as detailed below. Specific
guidance on switching well-co